Skip to content

Try premium free for 7 days.

Plans

Why is $VTGN stock up today?

Vistagen Therapeutics, Inc. Common Stock · Pharmaceutical Preparations

Why is $VTGN up today?

The likely driver

Clinical / FDA update
Vistagen Therapeutics, Inc. filed an 8-K: Exit / Disposal Costs, Other Material Event
SEC filing · Oct 30
Price
$0.17
Move today
+0.7%
Volume vs avg
0.0x
Scanner alerts today
0
Flagged in 30 days
8
Market cap
$7M
Prev close
$0.17
Avg volume
10.7M

Catch the next move like VTGN before the open

Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Nothing has triggered on VTGN yet in this session. Our scanner has flagged it 8 times in the last 30 days , most recently on October 30 for unusual volume, which is why this page is here. See the full VTGN page for the chart and the alert history.

Earlier scanner activity on VTGN

  • Oct 30Unusual volume (RVOL) alert
  • Oct 30Unusual volume (RVOL) alert
  • Oct 29Unusual volume (RVOL) alert
  • Oct 28Unusual volume (RVOL) alert
  • Oct 23Unusual volume (RVOL) alert
  • Oct 23Unusual volume (RVOL) alert
  • Oct 23Unusual volume (RVOL) alert
  • Oct 13Unusual volume (RVOL) alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $VTGN alerts the moment volume spikes

Our scanner flagged $VTGN 8 times in the last 30 days. Create a free account to track $VTGN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.